Therapeutic strategy of chomposite of Platelet-Rich Plasma (PRP) and hydrogel for meniscal repair

Therapeutic strategy of chomposite of Platelet-Rich Plasma (PRP) and hydrogel for meniscal repair - Therapeutic strategy of chomposite of PRP and hydrogel for meniscal repair

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007284

Enrollment

Registered

2012-02-13

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee meniscal tear

Interventions

meniscal repair

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Meniscal tear diagnosed by physical examination and magnetic resonance image 2) 1. Longitudinal and vertical (bucket-handle) tear in or near vascular zone: meniscal repair and transplantation of PRP and hydrogel 2. meniscal tear except for the above: intra-articular injection of PRP 3) Informed consent by writing

Exclusion criteria

Exclusion criteria: 1) Patients receiving radiation, chemotherapy, immunosuppression, or chronic steroids 2) Patients with complete neuropathy that would interfere with walking or appreciation of pain 3) Patients with known sensitivity to gelatin 4) Patients with active infection systemically or at the site of knee 5) Patients joining in another clinical study

Design outcomes

Primary

Measure	Time frame
Evaluation of efficacy is whether injured meniscus is healed or not after 4 weeks after the treatment in MRI findings. Evaluation of safety is all harmful issues occurred during the study.	—

Countries

Japan

Contacts

Public ContactTomoyuki Matsumoto

Kobe University Graduate School of Medicine Department of Orthopaedic Surgery

matsun@m4.dion.ne.jp078-382-5985

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026